Central Admixture Pharmacy Services, Inc.: Drug Recall

Recall #D-0677-2023 · 04/28/2023

Class II: Risk

Recall Details

Recall Number: D-0677-2023
Classification: Class II
Product Type: Drug
Recalling Firm: Central Admixture Pharmacy Services, Inc.
Status: Terminated
Date Initiated: 04/28/2023
Location: Allentown, PA, United States
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 79 bags

Reason for Recall

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Product Description

Microplegia Solution, HIGH POTASSIUM (100 mEq), packaged in 200 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0213-1.

Distribution Pattern

Nationwide in the USA.

Other Recalls by Central Admixture Pharmacy Services, Inc.

Class I: Dangerous 02/20/2025

Presence of Particulate Matter
Class II: Risk 09/21/2023

Lack of assurance of sterility:
Class II: Risk 09/21/2023

Lack of assurance of sterility:
Class II: Risk 09/21/2023

Lack of assurance of sterility:
Class II: Risk 09/21/2023

Lack of assurance of sterility:

View all recalls by Central Admixture Pharmacy Services, Inc. →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.